Skip to main content

Nicotine Transdermal System

NDC 50742-669 · Ingenus Pharmaceuticals, LLC

Generic nameNicotine Transdermal System
Dosage formPATCH
RouteTRANSDERMAL
Active ingredient(s)NICOTINE
Strength14 mg/24h
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

50742-669-07 — 7 POUCH in 1 CARTON (50742-669-07) / 24 h in 1 POUCH

50742-669-14 — 14 POUCH in 1 CARTON (50742-669-14) / 24 h in 1 POUCH

50742-669-28 — 28 POUCH in 1 CARTON (50742-669-28) / 24 h in 1 POUCH

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-3560 — Nicotine Polacrilex, 50090-6240 — Nicotine Polacrilex, 50090-6383 — Nicotine, 50090-6674 — nicotine polacrilex, 50090-6695 — nicotine polacrilex, 50090-7060 — Nicotine Polacrilex, 50090-7061 — Nicotine Polacrilex, 50090-7063 — nicotine polacrilex, 50090-7936 — Nicotine, 50742-668 — Nicotine Transdermal System, 50742-670 — Nicotine Transdermal System, 51316-151 — Nicotine polacrilex, 51316-190 — Nicotine Polacrilex, 51316-309 — Nicotine Polacrilex, 51316-319 — nicotine polacrilex, 51316-787 — nicotine polacrilex, 53329-191 — nicotine, 53329-192 — nicotine, 53329-193 — nicotine, 55301-428 — Nicotine Polacrilex, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels